Helixcell Therapeutics Private Limited
About Helixcell Therapeutics Private Limited
Data last updated:
Helixcell Therapeutics Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the hardware consulting segment of the professional services sector. It was incorporated on 06 November 2023.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U72100TS2023PTC178764.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.09 Cr. It is led by directors including Kodali Murali Krishna and Rama Krishna Kodali.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.29 Lakh. For the same year it recorded a net loss of ₹4.33 Lakh (net margin -335.9%) and EBITDA of -₹4.33 Lakh (EBITDA margin -335.9%).
Company details
Contact details
Helixcell Therapeutics Private Limited's registered office is in Hyderabad, Telangana.
- Registered Address203 2nd Flr Sbr, Cv Towers, Hyderabad, Telangana, India – 500081
- IndustryProfessional Services, Hardware Consulting
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Helixcell Therapeutics Private Limited
FY 2025 filings availableHelixcell Therapeutics Private Limited reported revenue of ₹1.29 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹4.33 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹4.33 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -335.9% | |
| Net Profit Margin | -335.9% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Helixcell Therapeutics Private Limited, buy the company report.
Board of directors of Helixcell Therapeutics Private Limited
Helixcell Therapeutics has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kodali Murali Krishna | Director | 06 Nov 2023 | 2 Years 11 Months | Current |
| Rama Krishna Kodali | Director | 06 Nov 2023 | 2 Years 11 Months | Current |
| Lavanya Kodali | Director | 02 Sep 2024 | 2 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Helixcell Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Helixcell Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Helixcell Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Helixcell Therapeutics Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Lavanya Kodali was appointed as Director on 02 Sep 2024.
Frequently asked questions
Helixcell Therapeutics is an active private limited company based in Hyderabad, Telangana, India. The company works in hardware consulting, within the professional services industry. It was incorporated on 06 November 2023 (3+ years old) and is registered under CIN U72100TS2023PTC178764.
Helixcell Therapeutics has 3 current directors:
- Kodali Murali Krishna - Director
- Rama Krishna Kodali - Director
- Lavanya Kodali - Director
The latest financial statements of Helixcell Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Helixcell Therapeutics is U72100TS2023PTC178764. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Helixcell Therapeutics was incorporated on 06 November 2023, making it 3+ years old. It is registered with the Registrar of Companies, Hyderabad.
Lavanya Kodali was appointed as Director on 02 Sep 2024. Kodali Murali Krishna was appointed as Director on 06 Nov 2023. Rama Krishna Kodali was appointed as Director on 06 Nov 2023.
The registered office of Helixcell Therapeutics is at 203 2nd Flr Sbr, Cv Towers, Hyderabad, Telangana, India – 500081.
Helixcell Therapeutics operates in the professional services industry, in the hardware consulting segment.
Helixcell Therapeutics can be reached at its registered office: 203 2nd Flr Sbr, Cv Towers, Hyderabad, Telangana, India – 500081.
Helixcell Therapeutics is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
